EDACS-based opioid analgesic
/ Akela Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 17, 2015
Performance of the EDACS-accelerated Diagnostic Pathway in a Cohort of US Patients with Acute Chest Pain.
(PubMed)
- Crit Pathw Cardiol - "Within a US cohort of ED patients with symptoms concerning for ACS, sensitivity for MACE was 88.2%. We are unable to validate the EDACS-ADP as sufficiently sensitive for clinical use."
Journal • Acute Coronary Syndrome • Biosimilar • Pain
1 to 1
Of
1
Go to page
1